Results 41 to 50 of about 1,517,186 (231)

Patterns and Trends in the Use of Medications for COPD Control in a Cohort of 9476 Colombian Patients, 2017–2019

International Journal of COPD, 2023
Manuel Enrique Machado-Duque,1,2 Andrés Gaviria-Mendoza,1,2 Luis Fernando Valladales-Restrepo,1,2 Andrés González-Rangel,3 Maria Eugenia Laucho-Contreras,3,4 Jorge Enrique Machado-Alba1 1Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia,
Machado-Duque ME, Gaviria-Mendoza A, Valladales-Restrepo LF, González-Rangel A, Laucho-Contreras ME, Machado-Alba JE   +5 more
doaj  

COPD and glycopyrronium responsiveness assessment: An appraisal

Lung India, 2023
Clinical Trial Registration: ECR/159/Inst/WB/2013/RR-20 Background: Glycopyrronium bromide (a long-acting antimuscarinic agent: LAMA) appears pharmacokinetically suitable for testing bronchodilator responsiveness as salbutamol (short-acting β2-agonist ...
Parthasarathi Bhattacharyya, Dipanjan Saha, Moumita Chatterjee, Sayoni Sengupta, Debkanya Dey, Rajat Banerjee   +5 more
doaj   +1 more source

Is Asthma Remission a New Achievable Goal? A Review of the Current Drug-Related Evidence and Predictors. [PDF]

Allergy
ABSTRACT Advances in asthma therapies have shown that clinical remission may be an achievable therapeutic goal for patients with asthma. This review discusses the current definitions of remission in asthma, the predictors of remission, airway inflammation/epithelial damage in asthma remission, airway remodeling, paradigms in defining remission and ...
Gunaydin FE, Marcassa G, Olivieri B, Senna G, Caminati M.   +4 more
europepmc   +2 more sources

Twenty years of inhaler therapy: A nationwide drug utilization study

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to map nationwide trends and prescribing patterns in inhaler use from 2004 to 2023. In light of evolving clinical guidelines and attention to the environmental impact of inhalers within recent years, we also examined variation in prescribing behaviour and patient‐level treatment choices. Methods Using nationwide health registries,
Katrine Bitsch Johansen, Lars Christian Lund, Zandra Nymand Ennis, Andrew Scourfield, Anders Løkke, Sidsel Arnspang Pedersen   +5 more
wiley   +1 more source

Bronchodilator Reversibility Occurring during the Acute Phase of Paragonimiasis westermani Infection [PDF]

A 43-year-old woman was referred to our hospital with peripheral blood hypereosinophilia and abnormal chest X-ray findings. Her pleural effusion revealed hypereosinophilia and a low glucose level.
60529402, 倉井, 淳, クライ, ジュン, ヤマグチ, コウスケ, ハラダ, トモヤ, Kawasaki, Yuji, 4270, Tsukada, Akira, Takami, Hiroki, カワサキ, ユウジ, 575, シミズ, エイジ, 1795, Yamasaki, Akira, 100000447, ヤマサキ, アキラ, 原田, 智也, 100000926, 26728, 26727, 清水, 英治, Shimizu, Eiji, Kurai, Jun, 26724, 26726, 26725, 100000274, 70325009, 50187449, Osawa, Yoichi, 山口, 耕介, 3302, 100001127, Harada, Tomoya, 山崎, 章, 70529396, 4358, Yamaguchi, Kosuke   +37 more
core   +1 more source

Adherence to Inhalation Devices in Patients with Chronic Obstructive Pulmonary Disease

Patient Preference and Adherence, 2023
Luis Fernando Valladales-Restrepo,1– 3 María Camila Oyuela-Gutiérrez,3 Ana Camila Delgado-Araujo,1 Juliana Calvo-Salazar,1 Daniel Osorio-Bustamante,3 Cesar Eduardo Lerma-Barco,3 Jorge Enrique Machado-Alba1 1Grupo de Investigación en Farmacoepidemiología ...
Valladales-Restrepo LF, Oyuela-Gutiérrez MC, Delgado-Araujo AC, Calvo-Salazar J, Osorio-Bustamante D, Lerma-Barco CE, Machado-Alba JE   +6 more
doaj  

Advances in New Approach Methodologies at FDA's Division of Applied Regulatory Science

Clinical Pharmacology &Therapeutics, EarlyView.
New Approach Methodologies (NAMs) represent a paradigm shift in drug development and regulatory science, offering human‐relevant alternatives to traditional preclinical models. This mini‐review highlights recent advances in NAM development, validation, and regulatory application from FDA's Division of Applied Regulatory Science (DARS).
Ksenia Blinova, Kimberly Chiu, Anik Chaturbedi, Jahan Cooper, Tromondae K. Feaster, Paula L. Hyland, Lidiya Stavitskaya, Wendy W. Wu, Jeffry Florian, Rodney Rouse   +9 more
wiley   +1 more source

Short-acting β2-agonist prescriptions in patients with asthma: findings from the South Korean cohort of SABINA III [PDF]

The Korean Journal of Internal Medicine
Background/Aims Despite short-acting β2-agonist (SABA) overuse being associated with poor asthma outcomes, data on SABA use in South Korea is scarce.
Kwang-Ha Yoo, Sang-Ha Kim, Sang-Heon Kim, Ji-Yong Moon, Heung-Woo Park, Yoon-Seok Chang, Maarten J.H.I Beekman   +6 more
doaj   +1 more source

Therapeutic‐dose verapamil‐induced cardiogenic shock in an older patient: a case report

Journal of Pharmacy Practice and Research, EarlyView.
Abstract Background Calcium channel blocker (CCB) toxicity most commonly follows deliberate overdose. However, severe toxicity at therapeutic doses may occur in susceptible individuals. Severe CCB toxicity often presents with clinical features of bradycardia, hypotension, hyperglycaemia, and lactic acidosis.
Christopher Thuring, Maria Carey, Timothy Webber, Biswadev Mitra   +3 more
wiley   +1 more source

Patterns of bronchodilator therapy in asthmatic outpatients [PDF]

, 2023
Background: Bronchodilators are used to treat asthma symptoms. The administration of this therapy can be given through monotherapy or in combination to achieve the maximum therapeutic effect. Objective: This study aimed to examine the prescribing pattern
Alfian N. Rasyid, Ni Putu Cintyadewi, -, Alfian Nur Rasyid, Arina D. Puspitasari, Alfian Nur Rasyid, -, Toetik Aryani, -, Arina Dery Puspitasari, Riska Kholifatul Rahmawati, -, Toetik Aryani, Riska K. Rahmawati, Samirah Samirah, Ni Putu Cintyadewi, Samirah, -, Riska Kholifatul Rahmawati, Arina Dery Puspitasari, -, Ni P. Cintyadewi   +15 more
core   +1 more source